BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8945479)

  • 1. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
    Yamaguchi H; Hendrickson WA
    Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
    Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
    J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
    Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
    J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of the SH2 and SH3 domains of the lck tyrosine protein kinase.
    Reynolds PJ; Hurley TR; Sefton BM
    Oncogene; 1992 Oct; 7(10):1949-55. PubMed ID: 1408136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico activation of Src tyrosine kinase reveals the molecular basis for intramolecular autophosphorylation.
    Mendieta J; Gago F
    J Mol Graph Model; 2004 Oct; 23(2):189-98. PubMed ID: 15363460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
    Veillette A; Caron L; Fournel M; Pawson T
    Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for regulation of Src by the docking protein p130Cas.
    Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR
    J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytoplasmic domain of rat NKR-P1 receptor interacts with the N-terminal domain of p56(lck) via cysteine residues.
    Campbell KS; Giorda R
    Eur J Immunol; 1997 Jan; 27(1):72-7. PubMed ID: 9022000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth transformation of human T cells by herpesvirus saimiri requires multiple Tip-Lck interaction motifs.
    Heck E; Friedrich U; Gack MU; Lengenfelder D; Schmidt M; Müller-Fleckenstein I; Fleckenstein B; Ensser A; Biesinger B
    J Virol; 2006 Oct; 80(20):9934-42. PubMed ID: 17005671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src protein-tyrosine kinase structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1155-64. PubMed ID: 15504335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
    Krystal GW; DeBerry CS; Linnekin D; Litz J
    Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells.
    Pignata C; Prasad KV; Hallek M; Druker B; Rudd CE; Robertson MJ; Ritz J
    Cell Immunol; 1995 Oct; 165(2):211-6. PubMed ID: 7553885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of an activated form of the protein tyrosine kinase Lck from an Escherichia coli expression system.
    Flint NA; Amrein KE; Jascur T; Burn P
    J Cell Biochem; 1994 Jul; 55(3):389-97. PubMed ID: 7962172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lck SH2 phosphotyrosine binding site is critical for efficient TCR-induced processive tyrosine phosphorylation of the zeta-chain and IL-2 production.
    Lewis LA; Chung CD; Chen J; Parnes JR; Moran M; Patel VP; Miceli MC
    J Immunol; 1997 Sep; 159(5):2292-300. PubMed ID: 9278318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P56lck A lymphocyte specific protein tyrosine kinase: activation, regulation and signal transduction.
    Fischer S; Marie-Cardine A; Ramos-Morales F; Bougeret C; Soula M; Maridonneau-Parini I; Benarous R
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):605-9. PubMed ID: 7981618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.
    Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G
    Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.